SDIX's Q4 Revenues, Loss Decline

The firm, formerly known as Strategic Diagnostics, saw an increase in kit sales, but not enough to offset a 21 percent decline in life science revenue.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories